was read the article
array:24 [ "pii" => "S2387020619304280" "issn" => "23870206" "doi" => "10.1016/j.medcle.2018.07.024" "estado" => "S300" "fechaPublicacion" => "2019-11-15" "aid" => "4606" "copyright" => "Elsevier España, S.L.U.. All rights reserved" "copyrightAnyo" => "2018" "documento" => "simple-article" "crossmark" => 1 "subdocumento" => "crp" "cita" => "Med Clin. 2019;153:372" "abierto" => array:3 [ "ES" => false "ES2" => false "LATM" => false ] "gratuito" => false "lecturas" => array:1 [ "total" => 0 ] "Traduccion" => array:1 [ "es" => array:19 [ "pii" => "S0025775318305049" "issn" => "00257753" "doi" => "10.1016/j.medcli.2018.07.008" "estado" => "S300" "fechaPublicacion" => "2019-11-15" "aid" => "4606" "copyright" => "Elsevier España, S.L.U." "documento" => "simple-article" "crossmark" => 1 "subdocumento" => "crp" "cita" => "Med Clin. 2019;153:372" "abierto" => array:3 [ "ES" => false "ES2" => false "LATM" => false ] "gratuito" => false "lecturas" => array:2 [ "total" => 6 "formatos" => array:2 [ "HTML" => 4 "PDF" => 2 ] ] "es" => array:10 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Carta científica</span>" "titulo" => "Parálisis periódica hipopotasémica tirotóxica, a propósito de un caso" "tienePdf" => "es" "tieneTextoCompleto" => "es" "paginas" => array:1 [ 0 => array:1 [ "paginaInicial" => "372" ] ] "titulosAlternativos" => array:1 [ "en" => array:1 [ "titulo" => "Hypokalemic thyrotoxic periodic paralysis. Report of one case" ] ] "contieneTextoCompleto" => array:1 [ "es" => true ] "contienePdf" => array:1 [ "es" => true ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "José León, Neus Muñoz, Angel Rivero" "autores" => array:3 [ 0 => array:2 [ "nombre" => "José" "apellidos" => "León" ] 1 => array:2 [ "nombre" => "Neus" "apellidos" => "Muñoz" ] 2 => array:2 [ "nombre" => "Angel" "apellidos" => "Rivero" ] ] ] ] ] "idiomaDefecto" => "es" "Traduccion" => array:1 [ "en" => array:9 [ "pii" => "S2387020619304280" "doi" => "10.1016/j.medcle.2018.07.024" "estado" => "S300" "subdocumento" => "" "abierto" => array:3 [ "ES" => false "ES2" => false "LATM" => false ] "gratuito" => false "lecturas" => array:1 [ "total" => 0 ] "idiomaDefecto" => "en" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S2387020619304280?idApp=UINPBA00004N" ] ] "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0025775318305049?idApp=UINPBA00004N" "url" => "/00257753/0000015300000009/v1_201910300628/S0025775318305049/v1_201910300628/es/main.assets" ] ] "itemSiguiente" => array:19 [ "pii" => "S2387020619304334" "issn" => "23870206" "doi" => "10.1016/j.medcle.2019.01.036" "estado" => "S300" "fechaPublicacion" => "2019-11-15" "aid" => "4750" "copyright" => "Elsevier España, S.L.U." "documento" => "simple-article" "crossmark" => 1 "subdocumento" => "cor" "cita" => "Med Clin. 2019;153:e47-e48" "abierto" => array:3 [ "ES" => false "ES2" => false "LATM" => false ] "gratuito" => false "lecturas" => array:1 [ "total" => 0 ] "en" => array:11 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Letter to the Editor</span>" "titulo" => "Efficacy of mefloquine and mirtazapine on progressive multifocal leukoencephalopathy in a patient with peripheral T-cell lymphoma" "tienePdf" => "en" "tieneTextoCompleto" => "en" "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "e47" "paginaFinal" => "e48" ] ] "titulosAlternativos" => array:1 [ "es" => array:1 [ "titulo" => "Eficacia de mefloquina y mirtazapina sobre la leucoencefalopatía multifocal progresiva en un paciente con linfoma T periférico" ] ] "contieneTextoCompleto" => array:1 [ "en" => true ] "contienePdf" => array:1 [ "en" => true ] "resumenGrafico" => array:2 [ "original" => 0 "multimedia" => array:7 [ "identificador" => "fig0005" "etiqueta" => "Fig. 1" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "figura" => array:1 [ 0 => array:4 [ "imagen" => "gr1.jpeg" "Alto" => 1749 "Ancho" => 2333 "Tamanyo" => 312382 ] ] "descripcion" => array:1 [ "en" => "<p id="spar0005" class="elsevierStyleSimplePara elsevierViewall">Brain MRI images with contrast in T1 sequence (upper) and FLAIR (lower). (A) At the time of PML diagnosis. (B and C) Month 3 and 6, respectively, after onset of the combined treatment with mirtazapine and mefloquine.</p>" ] ] ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "Marta Peña, Silvia Presas-Rodríguez, Josep-Maria Ribera" "autores" => array:3 [ 0 => array:2 [ "nombre" => "Marta" "apellidos" => "Peña" ] 1 => array:2 [ "nombre" => "Silvia" "apellidos" => "Presas-Rodríguez" ] 2 => array:2 [ "nombre" => "Josep-Maria" "apellidos" => "Ribera" ] ] ] ] ] "idiomaDefecto" => "en" "Traduccion" => array:1 [ "es" => array:9 [ "pii" => "S0025775319300508" "doi" => "10.1016/j.medcli.2019.01.004" "estado" => "S300" "subdocumento" => "" "abierto" => array:3 [ "ES" => false "ES2" => false "LATM" => false ] "gratuito" => false "lecturas" => array:1 [ "total" => 0 ] "idiomaDefecto" => "es" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0025775319300508?idApp=UINPBA00004N" ] ] "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S2387020619304334?idApp=UINPBA00004N" "url" => "/23870206/0000015300000009/v1_201911071124/S2387020619304334/v1_201911071124/en/main.assets" ] "itemAnterior" => array:19 [ "pii" => "S2387020619304371" "issn" => "23870206" "doi" => "10.1016/j.medcle.2019.04.022" "estado" => "S300" "fechaPublicacion" => "2019-11-15" "aid" => "4889" "copyright" => "Elsevier España, S.L.U." "documento" => "article" "crossmark" => 1 "subdocumento" => "sco" "cita" => "Med Clin. 2019;153:368-71" "abierto" => array:3 [ "ES" => false "ES2" => false "LATM" => false ] "gratuito" => false "lecturas" => array:1 [ "total" => 0 ] "en" => array:11 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Special article</span>" "titulo" => "Bullous pemphigoid and DPP4 inhibitors" "tienePdf" => "en" "tieneTextoCompleto" => "en" "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "368" "paginaFinal" => "371" ] ] "titulosAlternativos" => array:1 [ "es" => array:1 [ "titulo" => "Penfigoide ampolloso e inhibidores de la DPP4" ] ] "contieneTextoCompleto" => array:1 [ "en" => true ] "contienePdf" => array:1 [ "en" => true ] "resumenGrafico" => array:2 [ "original" => 0 "multimedia" => array:8 [ "identificador" => "fig0005" "etiqueta" => "Fig. 1" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "figura" => array:1 [ 0 => array:4 [ "imagen" => "gr1.jpeg" "Alto" => 1937 "Ancho" => 4445 "Tamanyo" => 1106149 ] ] "detalles" => array:1 [ 0 => array:3 [ "identificador" => "at0005" "detalle" => "Fig. " "rol" => "short" ] ] "descripcion" => array:1 [ "en" => "<p id="spar0005" class="elsevierStyleSimplePara elsevierViewall">82-year-old female patient with type 2 diabetes mellitus in therapy with linagliptin. Three and a half months after the start of treatment, blistering and erosive lesions begin to appear (left). Confirmed diagnosis of bullous pemphigoid; refractory to doses of prednisone of up to 2 mg/kg/day and intensified topical cures (applied poultice using zinc sulfate and betamethasone valerate gentamicin sulfate every 6 h). On suspicion of BP associated with iDPP-4, linagliptin is withdrawn and replaced with insulin. After eight days (centre), the patient undergoes a significant clinical improvement, with partial epithelialization of the lesions, without modifications in the treatment of BP. We decided to reduce the doses of prednisone to 1 mg/kg/day. In fewer than 30 days, medium-sized lesions completely epithelized and large lesions had a very favourable evolution (right). The glucocorticoid regime is gradually decreased with complete healing one and a half months after withdrawal of iDPP-4.</p>" ] ] ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "Rubén García Castro, Elena Godoy Gijón, Ana María González Pérez, Concepción Román Curto" "autores" => array:4 [ 0 => array:2 [ "nombre" => "Rubén" "apellidos" => "García Castro" ] 1 => array:2 [ "nombre" => "Elena" "apellidos" => "Godoy Gijón" ] 2 => array:2 [ "nombre" => "Ana María" "apellidos" => "González Pérez" ] 3 => array:2 [ "nombre" => "Concepción" "apellidos" => "Román Curto" ] ] ] ] ] "idiomaDefecto" => "en" "Traduccion" => array:1 [ "es" => array:9 [ "pii" => "S0025775319304075" "doi" => "10.1016/j.medcli.2019.04.031" "estado" => "S300" "subdocumento" => "" "abierto" => array:3 [ "ES" => false "ES2" => false "LATM" => false ] "gratuito" => false "lecturas" => array:1 [ "total" => 0 ] "idiomaDefecto" => "es" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0025775319304075?idApp=UINPBA00004N" ] ] "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S2387020619304371?idApp=UINPBA00004N" "url" => "/23870206/0000015300000009/v1_201911071124/S2387020619304371/v1_201911071124/en/main.assets" ] "en" => array:13 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Scientific letter</span>" "titulo" => "Hypokalemic thyrotoxic periodic paralysis. Report of one case" "tieneTextoCompleto" => true "saludo" => "Dear Editor," "paginas" => array:1 [ 0 => array:1 [ "paginaInicial" => "372" ] ] "autores" => array:1 [ 0 => array:4 [ "autoresLista" => "José León, Neus Muñoz, Angel Rivero" "autores" => array:3 [ 0 => array:3 [ "nombre" => "José" "apellidos" => "León" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">a</span>" "identificador" => "aff0005" ] ] ] 1 => array:4 [ "nombre" => "Neus" "apellidos" => "Muñoz" "email" => array:1 [ 0 => "neus85@gmail.com" ] "referencia" => array:2 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">b</span>" "identificador" => "aff0010" ] 1 => array:2 [ "etiqueta" => "*" "identificador" => "cor0005" ] ] ] 2 => array:3 [ "nombre" => "Angel" "apellidos" => "Rivero" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">b</span>" "identificador" => "aff0010" ] ] ] ] "afiliaciones" => array:2 [ 0 => array:3 [ "entidad" => "Departamento de Endocrinología y Nutrición, Hospital Corporació Parc Taulí, Sabadell, Barcelona, Spain" "etiqueta" => "a" "identificador" => "aff0005" ] 1 => array:3 [ "entidad" => "Departamento de Medicina Interna, Hospital Corporació Parc Taulí, Sabadell, Barcelona, Spain" "etiqueta" => "b" "identificador" => "aff0010" ] ] "correspondencia" => array:1 [ 0 => array:3 [ "identificador" => "cor0005" "etiqueta" => "⁎" "correspondencia" => "Corresponding author." ] ] ] ] "titulosAlternativos" => array:1 [ "es" => array:1 [ "titulo" => "Parálisis periódica hipopotasémica tirotóxica, a propósito de un caso" ] ] "textoCompleto" => "<span class="elsevierStyleSections"><p id="par0005" class="elsevierStylePara elsevierViewall">Hypokalemic thyrotoxic periodic paralysis (HTPP) is a rare entity, a neuromuscular complication of hyperthyroidism. It is more common in male and Asian patients.<a class="elsevierStyleCrossRef" href="#bib0025"><span class="elsevierStyleSup">1</span></a></p><p id="par0010" class="elsevierStylePara elsevierViewall">We present the case of a patient affected by HTPP.</p><p id="par0015" class="elsevierStylePara elsevierViewall">A 35-year-old Bolivian male patient, with a family history of hyperthyroidism on his mother's side, no toxic habits and no previous pathological history of interest. The patient goes to the emergency department due to generalized weakness with stiffness, muscle cramps and tingling from awakening. The patient reports having lost 20<span class="elsevierStyleHsp" style=""></span>kg of weight this past year, with palpitations along with occasional loose stools with no blood, pus or mucus. Physical examination showed rhythmic heart rate, tachycardia and normal vesicular breath sounds. Neurologically the patient shows normal language, visual field test and cranial nerves. Tetraparesis of proximal predominance. Muscle stimulation (right side): deltoids 2/5, biceps 3/5, triceps and rest of distal muscles 4/5. Muscle stimulation (left side): deltoids 2/5, biceps 2/5, triceps and rest of distal muscles 3/5. Both lower limbs at proximal level 2/5, distal level 3−/5. RMT 1/5 globally. Flexor plantar reflex. The patient has no sensory deficits or sensory level. ECG shows sinus tachycardia with no alterations in QT interval. Blood test with hypokalemia of 1.6<span class="elsevierStyleHsp" style=""></span>mEq/l and rest of parameters within normal levels. Therefore, we started replacement with potassium chloride ev. The blood study is completed with thyrotropin (TSH) <0.014<span class="elsevierStyleHsp" style=""></span>μU/ml, free T4 2.46<span class="elsevierStyleHsp" style=""></span>ng/dl, free T3 4.75<span class="elsevierStyleHsp" style=""></span>pg/ml. It is treated as a hypokalemic thyrotoxic periodic paralysis, therefore the therapy used is propranolol 10<span class="elsevierStyleHsp" style=""></span>mg/8<span class="elsevierStyleHsp" style=""></span>h orally along with thiamazole 5<span class="elsevierStyleHsp" style=""></span>mg/12<span class="elsevierStyleHsp" style=""></span>h. During admission, potassium levels go back to normal along with the patient's symptoms, and the muscle balance improves by 4/5 of all 4 limbs. Thyroid ultrasound is requested that shows moderate growth of the thyroid gland with diffusely heterogeneous echo structure with a few nodules, the largest of 9<span class="elsevierStyleHsp" style=""></span>mm in the right lobe suggestive of thyroiditis without any significant lymphadenopathies. In the blood test, anti-thyroid peroxidase antibodies (TPO) >600<span class="elsevierStyleHsp" style=""></span>IU/ml and anti-thyroglobulin (TG) antibodies 17.5<span class="elsevierStyleHsp" style=""></span>IU/ml stand out. During admission, thyroid scintigraphy showed an enlarged thyroid gland including both lobes (RTL<span class="elsevierStyleHsp" style=""></span>><span class="elsevierStyleHsp" style=""></span>LTL), with normal location and morphology. Tracer uptake by the thyroid parenchyma is increased, which confirms the state of thyroid gland hyperfunction. The diagnosis of Graves–Basedow disease is confirmed facing these results.</p><p id="par0020" class="elsevierStylePara elsevierViewall">In conclusion, HTPP is a very rare disease in our western environment, being more typical in Asian patients. The pathophysiology of this disease is not entirely well defined, but hypokalemia is due to a hyperactive sodium/potassium ATPase pump. This stimulation can be attributed to other etiologies such as hyperinsulinism, resting and the use of beta-adrenergic agents. This is why the first line therapy should be the correction of dyselectrolytemias, hyperthyroidsm and the use of beta blockers to inhibit the activity of the ATPase pump. Some studies have reported the use of prophylactic beta-blockers to prevent the decrease of extracellular potassium, as well as the conversion of T4 to T3, but further research is required.<a class="elsevierStyleCrossRefs" href="#bib0030"><span class="elsevierStyleSup">2–4</span></a> We believe that this case is relevant since hyperthyroidism is a very widespread disease, and is a diagnosis to take into account when muscle weakness occurs.</p></span>" "pdfFichero" => "main.pdf" "tienePdf" => true "NotaPie" => array:1 [ 0 => array:2 [ "etiqueta" => "☆" "nota" => "<p class="elsevierStyleNotepara" id="npar0005">Please cite this article as: León J, Muñoz N, Rivero A. Parálisis periódica hipopotasémica tirotóxica, a propósito de un caso. Med Clin (Barc). 2019;153:372.</p>" ] ] "bibliografia" => array:2 [ "titulo" => "References" "seccion" => array:1 [ 0 => array:2 [ "identificador" => "bibs0015" "bibliografiaReferencia" => array:4 [ 0 => array:3 [ "identificador" => "bib0025" "etiqueta" => "1" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Clinical review: Thyrotoxic periodic paralysis: a diagnostic challenge" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:1 [ 0 => "A.W. Kung" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1210/jc.2006-0356" "Revista" => array:7 [ "tituloSerie" => "J Clin Endocrinol Metab" "fecha" => "2006" "volumen" => "91" "paginaInicial" => "2490" "paginaFinal" => "2495" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/16608889" "web" => "Medline" ] ] "itemHostRev" => array:3 [ "pii" => "S0749806315008336" "estado" => "S300" "issn" => "07498063" ] ] ] ] ] ] ] 1 => array:3 [ "identificador" => "bib0030" "etiqueta" => "2" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Mechanism of thyrotoxic periodic paralysis" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:2 [ 0 => "S.H. Lin" 1 => "C.L. Huang" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1681/ASN.2012010046" "Revista" => array:6 [ "tituloSerie" => "J Am Soc Nephrol" "fecha" => "2012" "volumen" => "23" "paginaInicial" => "985" "paginaFinal" => "988" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/22460532" "web" => "Medline" ] ] ] ] ] ] ] ] 2 => array:3 [ "identificador" => "bib0035" "etiqueta" => "3" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Thyrotoxic periodic paralysis: an unusual presentation of hyperthyroidism" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "M. Salih" 1 => "R.P. Kinschot" 2 => "R.P. Peeters" 3 => "W.W. Herder" 4 => "E.J.J. Duschek" 5 => "J. Linden" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "Neth J Med" "fecha" => "2017" "volumen" => "75" "paginaInicial" => "315" "paginaFinal" => "320" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/29219824" "web" => "Medline" ] ] ] ] ] ] ] ] 3 => array:3 [ "identificador" => "bib0040" "etiqueta" => "4" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Metabolic disorders and nutritional status in autoimmune thyroid diseases" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:2 [ 0 => "A. Kawicka" 1 => "B. Regulska-Ilow" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:5 [ "tituloSerie" => "Postepy Hig Med Dosw" "fecha" => "2015" "volumen" => "69" "paginaInicial" => "80" "paginaFinal" => "90" ] ] ] ] ] ] ] ] ] ] ] "idiomaDefecto" => "en" "url" => "/23870206/0000015300000009/v1_201911071124/S2387020619304280/v1_201911071124/en/main.assets" "Apartado" => array:4 [ "identificador" => "43311" "tipo" => "SECCION" "en" => array:2 [ "titulo" => "Scientific letters" "idiomaDefecto" => true ] "idiomaDefecto" => "en" ] "PDF" => "https://static.elsevier.es/multimedia/23870206/0000015300000009/v1_201911071124/S2387020619304280/v1_201911071124/en/main.pdf?idApp=UINPBA00004N&text.app=https://www.elsevier.es/" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S2387020619304280?idApp=UINPBA00004N" ]